Medicare Part D does not cover Wegovy for weight loss
Medicare Part D, which covers prescription drugs, does not pay for Wegovy (semaglutide) when it is used for weight management. Part D covers medications that treat medical conditions, and Medicare has determined that weight loss itself is not a medical condition that Part D should cover. This means you would pay the full cost of Wegovy out of your own pocket if you want to use it for weight loss.
However, the situation is more complicated if you have type 2 diabetes. Wegovy's sister medication, Ozempic (also semaglutide), is approved to treat diabetes and may be covered by Part D if your doctor prescribes it for that reason. The two medications are chemically identical, but Medicare distinguishes between them based on the reason your doctor writes the prescription.
Key Takeaways
- Medicare Part D does not cover Wegovy when prescribed for weight loss, even though the medication is FDA-approved for that use.
- If you have type 2 diabetes, Ozempic (the diabetes version of the same drug) may be covered by Part D, depending on your specific plan.
- Private insurance coverage of Wegovy varies widely by plan and employer, so you will need to contact your insurer directly to find out what you pay.
- The full cash price of Wegovy is typically between $900 and $1,350 per month, though the manufacturer offers a discount program that can lower this cost.
- Some Medicare Advantage plans (Part C) may cover weight-loss medications, so it is worth checking your plan documents if you have one.
Why Medicare Part D does not cover weight-loss medications
Medicare Part D was designed to cover drugs that treat disease. The Centers for Medicare & Medicaid Services (CMS) views obesity as a risk factor for disease rather than a disease itself that Part D should address. This distinction matters: Part D will pay for insulin to treat diabetes, but not for a weight-loss drug even if losing weight would reduce your diabetes risk.
This policy applies to all weight-loss medications, not just Wegovy. GLP-1 drugs like Saxenda and Mounjaro, as well as older medications like phentermine, are also not covered by Part D for weight loss. The reasoning is consistent across the board: Part D covers treatment of existing conditions, not prevention of future ones through weight management.
What happens if you have type 2 diabetes
If your doctor prescribes Ozempic (semaglutide) to treat your type 2 diabetes, your Part D plan may cover it. Coverage depends on your specific plan, because each plan sets its own formulary — the list of drugs it will pay for. Some Part D plans cover Ozempic with no restrictions, some require you to try other diabetes medications first, and some do not cover it at all.
The key is the prescription reason. If your doctor writes the prescription for diabetes management, you have a chance at Part D coverage. If the prescription says "weight loss" or "obesity," Part D will not pay, even if you also have diabetes. You and your doctor may need to discuss how the prescription is worded.
To find out whether your specific Part D plan covers Ozempic, call the plan directly or log into your plan's website and search the formulary. You can also ask your pharmacy to check coverage before you fill the prescription.
Private insurance and Medicare Advantage coverage
If you have private insurance through a former employer or a spouse's plan, coverage of Wegovy varies significantly. Some plans cover it with a copay, some require prior authorization from your doctor, and some do not cover it at all. The only way to know is to contact your insurance company directly or check your plan documents.
Medicare Advantage plans (Part C) are run by private insurers and set their own drug coverage rules. Some Advantage plans do cover weight-loss medications, while others follow the same approach as traditional Medicare Part D. If you have an Advantage plan, check your plan's formulary or call the plan to ask about Wegovy coverage.
The cash price of Wegovy and manufacturer discounts
Without insurance coverage, Wegovy costs between $900 and $1,350 per month at most pharmacies, depending on your location and pharmacy. This is the price for the standard dose pens that most people use.
Novo Nordisk, the manufacturer, offers a savings program called Wegovy Savings Offer. If you have commercial insurance that does not cover Wegovy, or if you are uninsured, you may pay as little as $99 per month through this program. The program has income limits, so you will need to check whether you may have access to. You can learn more and enroll at the Novo Nordisk website or ask your pharmacy about the program.
Other weight-loss medications and their coverage
Saxenda (liraglutide) is another GLP-1 medication approved for weight loss, and it is also not covered by Medicare Part D. Mounjaro (tirzepatide) is a newer medication that is sometimes prescribed off-label for weight loss, though it is FDA-approved only for type 2 diabetes. Like Ozempic, Mounjaro may be covered by Part D if prescribed for diabetes.
Older weight-loss medications like phentermine and topiramate are also not covered by Part D for weight loss, though they are inexpensive and may cost $10 to $30 per month out of pocket. Your doctor can discuss whether any of these alternatives might work for you.
What to do if you want to use Wegovy
Start by contacting your Part D plan to confirm that Wegovy for weight loss is not covered. Ask specifically whether your plan covers Ozempic for diabetes, in case that option applies to you. If you have a Medicare Advantage plan, ask whether it covers any weight-loss medications.
If Part D will not pay, ask your doctor whether you may have access to for the Novo Nordisk savings program. You will need to provide income information, and there are limits based on household size, but many people find the $99 monthly cost manageable compared to the full price.
If the savings program does not work for you, discuss with your doctor whether a different weight-loss medication might be an option. Some older drugs are much cheaper out of pocket, and your doctor can help you weigh the benefits and drawbacks of each choice.
Frequently Asked Questions
Can I appeal if my Part D plan denies Wegovy?
You can file an appeal, but the appeal will likely be denied because Part D policy does not cover weight-loss medications. The appeal process exists for cases where a plan incorrectly denies a drug that should be covered under its own rules. Since Wegovy for weight loss is not supposed to be covered, an appeal is unlikely to change the outcome.
Will Medicare ever start covering Wegovy?
Medicare policy can change, but there is no current indication that Part D coverage of weight-loss medications is being reconsidered. Any change would require a decision by CMS, which would likely take years. For now, you should plan on paying out of pocket or using a manufacturer discount program.
What if my doctor says Wegovy is medically necessary for me?
Medical necessity is not the standard Medicare uses for Part D coverage. Even if your doctor believes Wegovy is necessary, Part D will not cover it for weight loss because of the policy that weight loss is not a covered reason. Your doctor can appeal on your behalf, but the outcome is unlikely to change based on medical judgment alone.
Does Medigap cover Wegovy if Part D does not?
Medigap plans cover the copays and deductibles that Medicare does not pay, but they do not cover drugs that Medicare Part D itself refuses to cover. Since Part D does not cover Wegovy for weight loss, Medigap will not either.
Can I use a GoodRx coupon or similar discount if I do not have insurance coverage?
Yes. GoodRx, SingleCare, and similar discount programs can sometimes offer prices lower than the pharmacy's standard price, though they are often higher than the Novo Nordisk savings program. It is worth checking both the manufacturer program and discount card prices before you fill the prescription.